Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
1.
Oncogene ; 36(46): 6501-6507, 2017 11 16.
Article in English | MEDLINE | ID: mdl-28759042

ABSTRACT

Malignant mesothelioma (MM) is an aggressive malignancy, highly resistant to current medical and surgical therapies, whose tumor cells characteristically show a high level of aneuploidy and genomic instability. We tested our hypothesis that targeting chromosomal instability in MM would improve response to therapy. Thr/Tyr kinase (TTK)/monopolar spindle 1 kinase (Mps-1) is a kinase of the spindle assembly checkpoint that controls cell division and cell fate. CFI-402257 is a novel, selective inhibitor of Mps-1 with antineoplastic activity. We found that CFI-402257 suppresses MM growth. We found that Mps-1 is overexpressed in MM and that its expression correlates with poor patients' outcome. In vitro, CFI-402257-mediated inhibition of Mps-1 resulted in abrogation of the mitotic checkpoint, premature progression through mitosis, marked aneuploidy and mitotic catastrophe. In vivo, CFI-402257 reduced MM growth in an orthotopic, syngeneic model, when used as a single agent, and more so when used in combination with cisplatin+pemetrexed, the current standard of care. Our preclinical findings indicate that CFI-402257 is a promising novel therapeutic agent to improve the efficacy of the current chemotherapeutic regimens for MM patients.


Subject(s)
Antineoplastic Agents/therapeutic use , Cell Cycle Proteins/antagonists & inhibitors , Lung Neoplasms/drug therapy , Mesothelioma/drug therapy , Protein Kinase Inhibitors/therapeutic use , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/antagonists & inhibitors , Pyrazoles/pharmacology , Pyrimidines/pharmacology , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/genetics , Cisplatin/administration & dosage , Gene Expression Regulation, Neoplastic/drug effects , Humans , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , M Phase Cell Cycle Checkpoints/drug effects , M Phase Cell Cycle Checkpoints/genetics , Mesothelioma/genetics , Mesothelioma/metabolism , Mesothelioma, Malignant , Mice, Inbred BALB C , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/genetics , Neoplasms, Experimental/metabolism , Pemetrexed/administration & dosage , Protein Kinase Inhibitors/administration & dosage , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/metabolism , Survival Analysis
2.
Oncogene ; 35(15): 1996-2002, 2016 Apr 14.
Article in English | MEDLINE | ID: mdl-26119930

ABSTRACT

Germline BAP1 mutations predispose to several cancers, in particular malignant mesothelioma. Mesothelioma is an aggressive malignancy generally associated with professional exposure to asbestos. However, to date, we found that none of the mesothelioma patients carrying germline BAP1 mutations were professionally exposed to asbestos. We hypothesized that germline BAP1 mutations might influence the asbestos-induced inflammatory response that is linked to asbestos carcinogenesis, thereby increasing the risk of developing mesothelioma after minimal exposure. Using a BAP1(+/-) mouse model, we found that, compared with their wild-type littermates, BAP1(+/-) mice exposed to low-dose asbestos fibers showed significant alterations of the peritoneal inflammatory response, including significantly higher levels of pro-tumorigenic alternatively polarized M2 macrophages, and lower levels of several chemokines and cytokines. Consistent with these data, BAP1(+/-) mice had a significantly higher incidence of mesothelioma after exposure to very low doses of asbestos, doses that rarely induced mesothelioma in wild-type mice. Our findings suggest that minimal exposure to carcinogenic fibers may significantly increase the risk of malignant mesothelioma in genetically predisposed individuals carrying germline BAP1 mutations, possibly via alterations of the inflammatory response.


Subject(s)
Asbestos, Crocidolite/toxicity , Mesothelioma/etiology , Peritoneal Neoplasms/etiology , Tumor Suppressor Proteins/genetics , Ubiquitin Thiolesterase/genetics , Animals , Asbestos, Crocidolite/administration & dosage , Ascitic Fluid/chemistry , Chemokines/analysis , Cytokines/analysis , Dose-Response Relationship, Drug , Female , Genetic Predisposition to Disease , Germ-Line Mutation , Heterozygote , Leukocytes/pathology , Macrophages, Peritoneal/classification , Macrophages, Peritoneal/physiology , Male , Mesothelioma/genetics , Mice , Mice, Inbred C57BL , Mineral Fibers/toxicity , Peritoneal Neoplasms/genetics , Peritonitis/etiology , Peritonitis/genetics , Random Allocation , Tumor Suppressor Proteins/deficiency , Tumor Suppressor Proteins/physiology , Ubiquitin Thiolesterase/deficiency , Ubiquitin Thiolesterase/physiology
3.
Cell Death Dis ; 6: e1786, 2015 Jun 11.
Article in English | MEDLINE | ID: mdl-26068794

ABSTRACT

High-mobility group box 1 (HMGB1) is an inflammatory molecule that has a critical role in the initiation and progression of malignant mesothelioma (MM). Aspirin (acetylsalicylic acid, ASA) is the most widely used nonsteroidal anti-inflammatory drug that reduces the incidence, metastatic potential and mortality of many inflammation-induced cancers. We hypothesized that ASA may exert anticancer properties in MM by abrogating the carcinogenic effects of HMGB1. Using HMGB1-secreting and -non-secreting human MM cell lines, we determined whether aspirin inhibited the hallmarks of HMGB1-induced MM cell growth in vitro and in vivo. Our data demonstrated that ASA and its metabolite, salicylic acid (SA), inhibit motility, migration, invasion and anchorage-independent colony formation of MM cells via a novel HMGB1-mediated mechanism. ASA/SA, at serum concentrations comparable to those achieved in humans taking therapeutic doses of aspirin, and BoxA, a specific inhibitor of HMGB1, markedly reduced MM growth in xenograft mice and significantly improved survival of treated animals. The effects of ASA and BoxA were cyclooxygenase-2 independent and were not additive, consistent with both acting via inhibition of HMGB1 activity. Our findings provide a rationale for the well documented, yet poorly understood antitumorigenic activity of aspirin, which we show proceeds via HMGB1 inhibition. Moreover, the use of BoxA appears to allow a more efficient HMGB1 targeting while eluding the known gastrointestinal side effects of ASA. Our findings are directly relevant to MM. Given the emerging importance of HMGB1 and its tumor-promoting functions in many cancer types, and of aspirin in cancer prevention and therapy, our investigation is poised to provide broadly applicable information.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Aspirin/therapeutic use , HMGB1 Protein/antagonists & inhibitors , Lung Neoplasms/drug therapy , Mesothelioma/drug therapy , Salicylic Acid/therapeutic use , 3T3 Cells , Animals , Antineoplastic Agents/therapeutic use , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/drug effects , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Epithelial-Mesenchymal Transition/drug effects , Female , HMGB1 Protein/metabolism , Lung Neoplasms/metabolism , Mesothelioma/metabolism , Mesothelioma, Malignant , Mice , Mice, Knockout , Mice, SCID , Neoplasm Invasiveness/pathology , Xenograft Model Antitumor Assays
4.
Kyobu Geka ; 62(1): 28-33, 2009 Jan.
Article in Japanese | MEDLINE | ID: mdl-19195183

ABSTRACT

Urgent pump conversion during off-pump coronary artery bypass (OPCAB) results in high morbidity and mortality. We retrospectively evaluated if the peri-operative integrated strategy prevents this lethal event in our 400 consecutive OPCAB operations. The patients with preoperative cardiogenic shock and/or ventricular arrhythmias underwent on-pump coronary artery bypass grafting (CABG). All other patients (99% of total CABG) were scheduled to undergo OPCAB (n=400). Prophylactic intraaortic balloon pumping (IABP) was applied to the patients with critical (>95%) left main trunk stenosis or low (<0.35) left ventricular ejection fraction. All the patients received the deep pericardial suture, apex-traction device, suction-type stabilizer, test-clamp of target coronary arteries by micro bulldog clamp, and intra-coronary shunts. Intra-operative IABP was applied in the case of sustained ST-segment change and/or elevated pulmonary artery pressure. Pump conversion was indicated for the patients with ventricular fibrillation and/or cardiogenic shock. Two patients (0.5%) had pump conversion due to ventricular arrhythmia and sustained hypotension, respectively. These pump conversion did not result in hospital mortality. Three hospital deaths (0.7%) occurred due to non-cardiac causes. The integrated strategy using prophylactic or intra-operative IABP in OPCAB produce a low pump conversion rate even during an early period of surgeon's learning curve.


Subject(s)
Coronary Artery Bypass, Off-Pump , Coronary Artery Bypass , Adolescent , Adult , Aged , Aged, 80 and over , Algorithms , Child , Female , Humans , Intra-Aortic Balloon Pumping , Male , Middle Aged
5.
Anticancer Res ; 20(4): 2779-83, 2000.
Article in English | MEDLINE | ID: mdl-10953357

ABSTRACT

MCF-7 cell growth is normally dependent upon estrogen, but if cells are maintained in serum-free medium estrogen inhibits cell growth with an IC50 of about 1 nM. Cells adapted to serum-free medium have approximately the same levels of estrogen receptor mRNA as control cells that are stimulated by estrogen. We have identified two serum components, one estrogen dependent and one not, that appear to be responsible for the inhibition of growth by estrogen. Our observations are consistent with the presence of a plasma membrane receptor which negatively regulates MCF-7 cell growth, and that can be inhibited by a serum protein that binds estrogen.


Subject(s)
Blood Proteins/physiology , Breast Neoplasms/prevention & control , Estrogens/pharmacology , Breast Neoplasms/pathology , Cell Division/drug effects , Culture Media, Serum-Free , Female , Humans , RNA, Messenger/analysis , Receptors, Estrogen/genetics , Tumor Cells, Cultured
6.
Anticancer Res ; 20(4): 2785-9, 2000.
Article in English | MEDLINE | ID: mdl-10953358

ABSTRACT

We have described two different proteins that mediate MCF-7 cell growth inhibition (1). One is estrogen-dependent and is a heterodimer consisting of a heavy (54 kDa) and light (29 kDa) chain. This protein is distinct from cortisol-binding globulin (CBG), sex hormone-binding protein (SBP or SHBG) and albumin (HSA). It may be fetal steroid binding protein (FSBP). The other is not estrogen dependent, but may be related to the estrogen-dependent protein. Since these are large proteins they must be acting at the level of the plasma membrane, not traditional intracellular estrogen receptors, and inhibit MCF-7 cell growth.


Subject(s)
Breast Neoplasms/prevention & control , Carrier Proteins/physiology , Estrogens/pharmacology , Fetal Proteins , Breast Neoplasms/pathology , Cell Division/drug effects , Female , Humans , Intracellular Signaling Peptides and Proteins , Sex Hormone-Binding Globulin/physiology , Tumor Cells, Cultured
8.
Biochem Biophys Res Commun ; 260(2): 365-70, 1999 Jul 05.
Article in English | MEDLINE | ID: mdl-10403776

ABSTRACT

Solid tumor cells are often exposed to hypoxia in vivo, which has been suggested to promote genetic instability in those cells. Telomere elongation by telomerase is implicated in chromosome stabilization in immortal cells. Here we found that hypoxia enhanced telomerase activity in the solid tumor A2780 and HT-29 cells but not in the leukemia U937 cells. The telomerase activation correlated with activation of mitogen-activated protein kinase (MAPK) and c-fos expression. The MEK1 inhibitor PD98059 repressed telomerase activation in the hypoxic cells. Consistently, a dominant negative MEK1 inhibited telomerase activation by hypoxia. Finally, we found a good correlation between telomerase activation and resistance to apoptotic cell death under hypoxic conditions. These findings indicate that hypoxia up-regulates telomerase activity via MAPK cascade signaling especially in solid tumor cells and suggest that solid tumor cells might enhance the telomerase activity as a stress response against genotoxicity induced by hypoxia.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Hypoxia , Neoplasms/enzymology , Signal Transduction , Telomerase/metabolism , Up-Regulation , Apoptosis , Base Sequence , DNA Primers , Gene Expression Regulation, Enzymologic , Humans , Neoplasms/metabolism , Neoplasms/pathology , Telomerase/genetics , Tumor Cells, Cultured
9.
Brain Res Mol Brain Res ; 64(2): 199-210, 1999 Feb 05.
Article in English | MEDLINE | ID: mdl-9931488

ABSTRACT

tal-1 (T-cell acute leukemia-1; also known as SCL) and tal-2 genes belong to a family of basic helix-loop-helix transcription factors and were originally isolated from the breakpoints of chromosomal translocations in human T-cell leukemia cell lines. tal-1 is expressed not only in hematopoietic cells but also in several endothelial structures and the central nervous system during development. On the other hand, the detailed function and the sites of expression of tal-2 have remained obscure. We cloned the tal-2 cDNA from a mouse embryonic cDNA library and examined its expression pattern in the mouse, comparing with that of tal-1. In situ analyses revealed that tal-2 transcripts are detected at embryonic day 12.5 in the following regions; 1) the diencephalon-the zona limitans intrathalamica and the pretectum, 2) the mesencephalon-the tectum, and the anterior and posterior tegmentum, 3) the metencephalon-the isthmus and the anterior pons. In the diencephalon and the mesencephalon, the expression sites of tal-2 gene were similar to those of tal-1, and its expression was stronger than that of tal-1. In the metencephalon, tal-2 expression was observed in the anterior pons, whereas tal-1 transcripts were detected in the entire pons, and showed stronger expression than tal-2. The tal-2 messages were barely detectable in the brain at birth. These results suggest that tal-1 and tal-2 are involved in the development of specific areas of the central nervous system.


Subject(s)
Brain/metabolism , DNA-Binding Proteins/genetics , Gene Expression Regulation, Enzymologic/physiology , Gene Expression Regulation, Neoplastic/physiology , Helix-Loop-Helix Motifs , Leukemia-Lymphoma, Adult T-Cell/genetics , Neoplasm Proteins/genetics , Amino Acid Sequence , Animals , Base Sequence , Basic Helix-Loop-Helix Transcription Factors , Brain/embryology , Brain/growth & development , Cloning, Molecular , Diencephalon/metabolism , Embryonic and Fetal Development/physiology , Humans , Mesencephalon/metabolism , Mice , Mice, Inbred ICR , Molecular Sequence Data , Pons/metabolism
10.
Nihon Kyobu Geka Gakkai Zasshi ; 44(12): 2146-50, 1996 Dec.
Article in Japanese | MEDLINE | ID: mdl-8990887

ABSTRACT

This report describes a 5-year-old girl with congenital tricuspid regurgitation associated with an atrial septal defect and peripheral pulmonary stenosis. The girl was diagnosed with the heart murmur at birth and recently developed the cardiomegaly. Cardiac echocardiography and catheterization showed severe tricuspid regurgitation, an atrial septal defect of the secundum type and peripheral pulmonary stenosis. In the operative findings, the tricuspid annulus was dilated to 33 mm in diameter, and leaflets were attached normally to the antomic annulus. There was a large cleft of the anterior leaflet of the tricuspid valve. Suture of the cleft and annuloplasty of the tricuspid valve, suture closure of the atrial septal defect and patch dilatation of peripheral pulmonary stenosis were successfully performed. Including this case, 19 other cases with congenital tricuspid regurgitation undergoing surgery were reported to date.


Subject(s)
Heart Septal Defects, Atrial/surgery , Pulmonary Valve Stenosis/surgery , Tricuspid Valve Insufficiency/surgery , Child, Preschool , Echocardiography , Female , Heart Septal Defects, Atrial/complications , Humans , Pulmonary Valve Stenosis/complications , Tricuspid Valve Insufficiency/complications , Tricuspid Valve Insufficiency/congenital
11.
J Thorac Cardiovasc Surg ; 112(3): 698-707, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8800158

ABSTRACT

BACKGROUND: Recent studies suggest that nitric oxide is important in the pathogenesis of ischemic brain injury and also has a role in controlling cerebrovascular tone. This study examines the net effects of nitric oxide on cerebral metabolic recovery after deep hypothermic circulatory arrest. METHODS: Two-week-old piglets were supported by cardiopulmonary bypass and cooled to 15 degrees C followed by 1 hour of deep hypothermic circulatory arrest, 45 minutes of reperfusion and rewarming, and then 3 hours of normothermic perfusion. Groups of 10 piglets received one of four treatments before bypass; L-nitro-arginine methyl ester, inhibitor of nitric oxide synthesis, 10 mg/kg intravenously; L-arginine, to enhance nitric oxide synthesis, 30 mg/kg intravenously before bypass and then 10 mg/kg per minute during the first hour of reperfusion; a combination of L-nitro-arginine methyl ester plus L-arginine at these same doses; and no pretreatment (controls). Cerebral high-energy phosphates and pH were measured by magnetic resonance spectroscopy in half the animals. Cerebral blood flow, metabolic rates for oxygen and glucose, and the oxidation/reduction state of cytochrome aa3 and oxygenated and deoxygenated hemoglobin measured by near-infrared spectroscopy were assessed in the other half of the piglets. RESULTS: L-nitro-arginine methyl ester significantly increased cerebral vascular resistance and markedly reduced recovery of high-energy phosphates, pH, and oxidation state of cytochrome aa3, L-arginine increased cerebral blood flow, cerebral glucose and oxygen consumption, and recovery of cytochrome aa3 oxidation and high-energy phosphates. L-Arginine did not reverse completely the effects of L-nitro-arginine methyl ester on cerebral metabolic recovery. CONCLUSION: In a piglet model of deep hypothermic circulatory arrest, L-nitro-arginine methyl ester has a deleterious effect and L-arginine has a beneficial effect on cerebral metabolic recovery. The deleterious metabolic effects of L-nitro-arginine methyl ester are only partially reversed by L-arginine. This fact suggests that there may be mechanisms in addition to inhibition of nitric oxide synthesis contributing to the neurotoxicity of L-nitro-arginine methyl ester in this model.


Subject(s)
Arginine/analogs & derivatives , Arginine/therapeutic use , Brain/metabolism , Enzyme Inhibitors/therapeutic use , Heart Arrest, Induced , Hypothermia, Induced , Nitric Oxide Synthase/antagonists & inhibitors , Animals , Arginine/administration & dosage , Brain/drug effects , Brain Ischemia/physiopathology , Cerebrovascular Circulation/drug effects , Disease Models, Animal , Electron Transport Complex IV/metabolism , Glucose/metabolism , Hemoglobins/metabolism , Hydrogen-Ion Concentration , Injections, Intravenous , Magnetic Resonance Spectroscopy , NG-Nitroarginine Methyl Ester , Nitric Oxide/pharmacology , Nitric Oxide/physiology , Oxidation-Reduction , Oxygen Consumption , Oxyhemoglobins/metabolism , Phosphates/metabolism , Reperfusion , Rewarming , Spectrophotometry, Infrared , Swine
12.
J Biochem ; 120(3): 647-56, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8902632

ABSTRACT

The complete primary structure of the major component of tuna pepsinogens was determined by conventional protein chemistry methods. It was composed of a prosegment of 37 residues and a pepsin moiety of 323 residues, having a relative molecular mass of 39,364. The essential aspartyl residues in the active site and the three disulfide bonds common to other pepsinogens were conserved; however, several unique substitutions and/or deletions characteristic of tuna pepsinogen were found at various positions, especially in the prosegment and subsite regions, as compared with the sequences of other pepsinogens, which may affect the rate of activation of the zymogen, and/or the catalytic function and substrate specificity of the enzyme. Tuna pepsinogen is the least acidic among pepsinogens. The sequence identity between tuna pepsinogen and other pepsinogens ranged from 45 to 52%. A phylogenetic tree based on the primary structures suggested that tuna pepsinogen diverged from the pepsinogen A and prochymosin groups in an early period of pepsinogen evolution.


Subject(s)
Gastric Mucosa/metabolism , Pepsinogens/chemistry , Amino Acid Sequence , Animals , Cathepsin D/chemistry , Chymotrypsin , Cyanogen Bromide , Humans , Molecular Sequence Data , Pepsin A/chemistry , Pepsinogens/isolation & purification , Peptide Fragments/chemistry , Peptide Fragments/isolation & purification , Phylogeny , Renin/chemistry , Sequence Homology, Amino Acid , Serine Endopeptidases , Thermolysin , Trypsin , Tuna
13.
Nihon Kyobu Geka Gakkai Zasshi ; 44(5): 653-8, 1996 May.
Article in Japanese | MEDLINE | ID: mdl-8964995

ABSTRACT

It is important to find a suitable vascular prosthesis as an intracardiac conduit for a total cavopulmonary connection because of the need for long-term patency. A 7-year-old girl with a double outlet of right ventricle, hypoplastic left ventricle, pulmonary atresia and single atrium with azygos connection underwent a total cavopulmonary connection using a knitted dacron prosthesis impregnated with gelatin (GELSEAL) as an intracardiac conduit. Her postoperative course was uneventful. GELSEAL is soft, easy to hand and effective at preventing blood loss. The conduit is also expected to have long-term patency because of good healing with thin and uniform pseudointimal formation. However, long-term patency especially in the right side of the heart is still unknown. She should be followed with close anticoagulant therapy and careful observation.


Subject(s)
Blood Vessel Prosthesis , Heart Defects, Congenital/surgery , Pulmonary Artery/surgery , Vena Cava, Inferior/surgery , Anastomosis, Surgical/methods , Child , Double Outlet Right Ventricle/surgery , Female , Gelatin , Humans , Polyethylene Terephthalates
14.
Sao Paulo Med J ; 114(3): 1186-9, 1996.
Article in English | MEDLINE | ID: mdl-9181751

ABSTRACT

Nineteen Brazilian HIV-infected hemophiliacs and their stable heterosexual sexual partners were studied with the aim of assessing the rate of HIV transmission in this at risk group. The mean length of relationship between couples was 7.4 years. The hemophiliac men were Class II (n = 6), III (n = 11) and IVa (n = 2) of the CDC classification. They had decreased CD4+ and elevated CD8+ cell numbers; five had p24 antigenemia. We found 3 HIV-infected women (15.8 percent) by routine and confirmatory tests, a prevalence similar to that seen in other countries. They were asymptomatic and had no detectable p24 antigenemia. The 3 seropositive women's partners were Class II and III-CDC, and had normal CD4+ and CD8+ values and no p24 antigenemia. All seronegative women also had normal CD4+ and CD8+ numbers, except for elevated CD8+ cells in three of them, but immune abnormalities had already been seen in some seronegative partners at high risk for HIV infection. Our results reinforce previous suggestions that heterosexual transmission to stable female partners occurs preferentially early after initiation of sexual exposure, and possibly when the transmitter had high levels of viremia and regular sexual activity.


PIP: In Brazil, hemophiliacs who received coagulation factor concentrates during 1980-85 have rates of HIV exceeding 50% and rates of heterosexual transmission to their partners in the range of 10-20%. This study investigated the clinical course of HIV infection in 19 male patients from a hematology center in Sao Paulo, Brazil, with hemophilia A or B and their stable, asymptomatic female sexual partners. The mean duration of the relationship was 7.4 years. Compared with 15 normal adult subjects used as controls, CD8+ cell counts of hemophiliacs were significantly higher while CD4+ cell values were significantly reduced. Three sexual partners (15.8%) were HIV-positive, implying a transmission rate of 2.1 per 100 person-years. All female partners were in Centers for Disease Control Class II. Their male partners were in Classes II and III and had normal CD4+ and CD8+ levels. Neither males nor females had p24 antigenemia. Fragments of HIV particles were present in several HIV-negative female partners. These findings suggests early HIV transmission, when the transmitter has high levels of viremia, to stable female partners of hemophiliacs.


Subject(s)
HIV Infections/transmission , Hemophilia A/complications , Sexual Partners , Adolescent , Adult , Aged , Blood Cell Count , Brazil , Female , HIV Infections/immunology , Humans , Male , Middle Aged , Risk Factors
18.
EMBO J ; 14(4): 685-96, 1995 Feb 15.
Article in English | MEDLINE | ID: mdl-7882972

ABSTRACT

We have identified the beta (beta) isoform of the 14-3-3 family of proteins as an activator of the Raf-1 protein kinase. 14-3-3 was isolated in a yeast two-hybrid screen for Raf-1 kinase domain binding proteins. Purified bovine brain 14-3-3 interacted specifically with both c-Raf-1 and the isolated Raf-1 kinase domain. Association was sensitive to the activation status of Raf-1; 14-3-3 bound to unactivated Raf-1, but not Raf-1 activated by protein kinase C alpha or Ras and Lck. The significance of these interactions under physiological conditions was demonstrated by co-immunoprecipitation of Raf-1 and 14-3-3 from extracts of quiescent, but not mitogen-stimulated, NIH 3T3 cells. 14-3-3 was not a preferred Raf-1 substrate in vitro and did not significantly affect Raf-1 kinase activity in a purified system. However, in cell-free extracts 14-3-3 acted as a Ras-independent activator of both c-Raf-1 and the Raf-1 kinase domain. The same results were obtained in vivo using transfection assays; 14-3-3 enhanced both c-Raf-1- and Raf-1 kinase domain-stimulated expression of AP-1- and NF-kappa B-dependent reporter genes and accelerated Raf-1 kinase domain-triggered differentiation of PC12 cells. We conclude that 14-3-3 is a latent co-activator bound to unactivated Raf-1 in quiescent cells and mediates mitogen-triggered but Ras-independent regulatory effects aimed directly at the kinase domain.


Subject(s)
Protein Serine-Threonine Kinases/metabolism , Proteins/metabolism , Proto-Oncogene Proteins/metabolism , Tyrosine 3-Monooxygenase , 14-3-3 Proteins , 3T3 Cells , Animals , Base Sequence , Cell-Free System , Cloning, Molecular , Enzyme Activation , Growth Substances/blood , Mice , Molecular Sequence Data , Protein Binding , Proto-Oncogene Proteins c-raf
19.
Transpl Int ; 8(5): 396-8, 1995.
Article in English | MEDLINE | ID: mdl-7576023

ABSTRACT

To evaluate the immunological properties of aluminum (Al) in experimental Al intoxication in rats, we performed heart transplantation and in vitro experiments. Lewis (Lew) rats were intoxicated with intraperitoneal injections of AlCl3. heart transplants were performed using Brown-Norway (BN) rats as donors. Isotransplants and normal Lew were used as controls. No differences in survival were observed. Unidirectional mixed lymphocyte cultures (MLC) and Concanavalin A (Con A)-stimulated cultures were prepared using spleen cells from normal and Al-intoxicated Lew rats. No differences were found in unidirectional MLC. Intoxicated cells showed a less intense response to con A than did normal cells. In conclusion, we could not detect an immunosuppressive role of Al intoxication in experimental cardiac transplantation or in MLC. However, the depressed Con A blastogenic response of Al-intoxicated cells may reflect an immunological role yet to be defined.


Subject(s)
Aluminum/toxicity , Heart Transplantation/immunology , Lymphocyte Activation/drug effects , Aluminum/immunology , Animals , Lymphocyte Culture Test, Mixed , Male , Rats , Rats, Inbred BN , Rats, Inbred Lew
SELECTION OF CITATIONS
SEARCH DETAIL
...